Stomach Ulcers Research Today is a free monthly online journal that collates and summarizes the latest research about Stomach Ulcers, including details on symptoms, treatment, causes, bleeding, medication.

Oral proton pump inhibitors are as effective as endoscopic treatment for bleeding peptic ulcer: a prospective, randomized, controlled trial.

Kim JI, Cheung DY, Cho SH, Park SH, Han JY, Kim JK, Han SW, Choi KY, Chung IS

Division of Gastroenterology, Department of Internal Medicine, The Catholic University of Korea, Korea.

In managing patients with bleeding peptic ulcers, it has been reported that pharmacologic treatment can be an alternative to endoscopic treatment. We compared the hemostasis rates of the endoscopic treatment, hemoclipping, and the pharmacologic treatment, oral proton pump inhibitors (PPIs), in bleeding peptic ulcer. A randomized prospective study was performed on 129 bleeding peptic ulcer patients with hematemesis or melena. Sixty-two patients were treated by endoscopic hemoclipping and subsequently H(2) receptor antagonists were injected intravenously (hemoclipping group), and 67 patients were treated with an oral PPI without endoscopic treatment (PPI group). The 24-hr gastric pH test was performed sequentially following the treatment. The initial hemostasis rate of the hemoclipping group was 93.5% (58/62) and the rebleeding rate was 6.9% (4/58), and the hemostasis rate of the PPI group was 92.5% (62/67) and the rebleeding rate was 7.5% (5/67), which were not different. The 24-hr gastric pH was 4.54+/-2.56 in the hemoclipping group and 5.97+/-1.30 in the PPI group (P<0.037). In the bleeding peptic ulcer patients, the hemostasis rate with the oral administration of PPIs was not different from that with the endoscopic hemoclipping treatment.

Published 8 November 2007 in Dig Dis Sci, 52(12): 3371-6.
Full-text of this article is available online (may require subscription).

© 2004-2008 Stomach Ulcers Research Today. All Rights Reserved.